🇺🇸 FDA
Pipeline program

DRUID AI Program

2022/00653

Phase 2 other active

Quick answer

DRUID AI Program for Solid Organ Malignancies is a Phase 2 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Solid Organ Malignancies
Phase
Phase 2
Modality
other
Status
active

Clinical trials